• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国乔治亚州亚特兰大便利样本中无症状百日咳带菌的评估。

Evaluation of Asymptomatic Bordetella Carriage in a Convenience Sample of Children and Adolescents in Atlanta, Georgia, United States.

机构信息

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

出版信息

J Pediatric Infect Dis Soc. 2024 Jan 29;13(1):105-109. doi: 10.1093/jpids/piad104.

DOI:10.1093/jpids/piad104
PMID:37974480
Abstract

Few data exist on asymptomatic carriage of Bordetella species among populations receiving acellular pertussis vaccine. We conducted a cross-sectional study among acellular-vaccinated children presenting to an emergency department (ED). Bordetella pertussis carriage prevalence was <1% in this population, a lower prevalence than that found in recent studies among whole-cell pertussis-vaccinated participants.

摘要

在接受无细胞百日咳疫苗的人群中,关于博德特氏菌属无症状携带的资料很少。我们在一个急诊科就诊的接受无细胞疫苗的儿童中进行了一项横断面研究。在该人群中,百日咳博德特氏菌的携带率<1%,低于最近在全细胞百日咳疫苗接种参与者中进行的研究中发现的携带率。

相似文献

1
Evaluation of Asymptomatic Bordetella Carriage in a Convenience Sample of Children and Adolescents in Atlanta, Georgia, United States.美国乔治亚州亚特兰大便利样本中无症状百日咳带菌的评估。
J Pediatric Infect Dis Soc. 2024 Jan 29;13(1):105-109. doi: 10.1093/jpids/piad104.
2
Pertussis in the Era of New Strains of Bordetella pertussis.百日咳博德特氏菌新菌株时代的百日咳
Infect Dis Clin North Am. 2015 Dec;29(4):699-713. doi: 10.1016/j.idc.2015.07.005. Epub 2015 Sep 1.
3
Pertussis vaccination and whooping cough: and now what?百日咳疫苗接种与百日咳:那么现在怎么办?
Expert Rev Vaccines. 2014 Oct;13(10):1163-5. doi: 10.1586/14760584.2014.941816. Epub 2014 Jul 14.
4
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.婴儿期接种的三组分无细胞百日咳疫苗在生命最初6年的持续效力:意大利的经验。
Pediatrics. 2001 Nov;108(5):E81. doi: 10.1542/peds.108.5.e81.
5
A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.俄罗斯圣彼得堡博德特氏菌血清阳性率的横断面研究及百日咳疫苗保护作用的估计持续时间。
Vaccine. 2018 Dec 18;36(52):7936-7942. doi: 10.1016/j.vaccine.2018.11.007. Epub 2018 Nov 15.
6
Pertussis vaccines.百日咳疫苗
Pediatr Clin North Am. 1990 Jun;37(3):549-66. doi: 10.1016/s0031-3955(16)36904-8.
7
Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.百日咳博德特氏菌和缺乏百日咳黏附素的临床分离株:百日咳疫苗的经验教训
Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23.
8
An expert panel opinion on protection against pertussis in Mexico: The role of acellular and whole-cell vaccines.墨西哥关于预防百日咳的专家小组意见:无细胞和全细胞疫苗的作用。
Bol Med Hosp Infant Mex. 2022;79(3):152-160. doi: 10.24875/BMHIM.21000150.
9
Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013.比较 2013 年法国百日咳学校聚集性病例全细胞与无细胞百日咳疫苗的有效性。
Med Mal Infect. 2020 Oct;50(7):617-619. doi: 10.1016/j.medmal.2020.07.004. Epub 2020 Jul 10.
10
Pertussis: challenges today and for the future.百日咳:当今及未来面临的挑战
PLoS Pathog. 2013;9(7):e1003418. doi: 10.1371/journal.ppat.1003418. Epub 2013 Jul 25.

引用本文的文献

1
Clinical and Epidemiological Characteristics of Pediatric Pertussis Cases: A Retrospective Study from Southeast Romania.罗马尼亚东南部小儿百日咳病例的临床和流行病学特征:一项回顾性研究
Antibiotics (Basel). 2025 Apr 23;14(5):428. doi: 10.3390/antibiotics14050428.